Cargando…
TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a multifunctional cytokine that binds with high affinity to a plasma membrane-anchored receptor named Fn14. Both TWEAK and Fn14 expression has been detected in human cancer tissue, and studies have shown that TWEAK/Fn14 signaling can pr...
Autores principales: | Armstrong, Cheryl L., Galisteo, Rebeca, Brown, Sharron A.N., Winkles, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348407/ https://www.ncbi.nlm.nih.gov/pubmed/27821799 http://dx.doi.org/10.18632/oncotarget.13034 |
Ejemplares similares
-
TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic
por: Cheng, Emily, et al.
Publicado: (2013) -
TWEAK-Independent Fn14 Self-Association and NF-κB Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain
por: Brown, Sharron A. N., et al.
Publicado: (2013) -
TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB
por: Hénaut, L, et al.
Publicado: (2016) -
The TWEAK Receptor Fn14 is a Novel Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
por: Zhou, Hong, et al.
Publicado: (2012) -
TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21
por: Sanz, Ana B., et al.
Publicado: (2010)